Brain changes that predict silent MS worsening over 5 years

Credibility

Interest

Share:2 min read

Key Takeaway

MRI signs of brain shrinkage and altered brain signals, together with age and mild disability, can predict silent long-term worsening in some people with MS.

What They Found

Researchers followed people with MS who had no new relapses or obvious new MRI lesions for five years and found one-third still showed steady disability worsening called PIRMA. People who worsened were on average older and had slightly more disability at the start, like walking or balance changes that are measured on a standard scale. Their brain MRIs showed more loss of brain tissue, especially in the gray matter (the cell-rich part of the brain), which you can think of like an engine losing parts over time. They also had changes in how different brain areas communicate at rest, seen as altered functional connectivity, which is like seeing traffic patterns change on a map even if roads look the same. When the team combined clinical measures (age and disability) with structural (brain volume) and functional MRI findings, these factors together helped predict who would silently worsen over five years.

Who Should Care and Why

People with MS and their caregivers should care because worsening can happen even without relapses or new MRI spots, so tracking subtle changes matters, like checking oil even if the car runs fine. Neurologists and care teams can use both brain volume measures and brain activity patterns to spot patients at higher risk, which may change monitoring frequency or treatment choices. Patients who are older or already have some disability should be especially attentive, because they were more likely to show silent progression in the study. Caregivers may notice small everyday changes—slower walking or thinking—that match the study’s findings and should report them, even if scans look unchanged by routine checks. This research supports asking for more detailed MRI checks and talking with your care team about symptoms that seem to slowly get worse.

Important Considerations

The study looked only at people who had no new relapses or obvious new MRI lesions, so results don’t apply to everyone with MS. MRI markers like brain volume and functional connectivity can help predict risk but are not perfect—some people who look at risk measures may still stay stable. This was an observational study, so it shows associations (links) but cannot prove one thing caused the other.

AI-generated summary — for informational purposes only, not medical advice

Categories:

MS Diagnostics Early Research MS Progression

Article Topics:

Multiple sclerosisPIRMAfunctional MRIsilent progressionstructural MRI

Whether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Multiple sclerosis (Houndmills, Basingstoke, England) often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.

However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.

By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.

Back to News